ENTRY       D05014                      Drug
NAME        Metreleptin (USAN/INN);
            Mettreleptin (genetical recombination) (JAN);
            Metreleptin (TN);
            Myalept (TN)
PRODUCT     MYALEPT (Amryt Pharmaceuticals DAC)
FORMULA     C714H1167N191O221S6
EXACT_MASS  16145.4275
MOL_WEIGHT  16155.4429
SEQUENCE    MVPIQKVQDD TKTLIKTIVT RINDISHTQS VSSKQKVTGL DFIPGLHPIL TLSKMDQTLA
            VYQQILTSMP SRNVIQISND LENLRDLLHV LAFSKSCHLP WASGLETLDS LGGVLEASGY
            STEVVALSRL QGSLQDMLWQ LDLSPGC (Disulfide bridge: 97-147)
  TYPE      Peptide
REMARK      Therapeutic category: 2499
            ATC code: A16AA07
            Product: D05014<JP/US>
EFFICACY    Metabolic homeostasis regulator, Leptin receptor agonist
  DISEASE   Lipodystrophy [DS:H01475]
COMMENT     Leptin [CPD:C18188] analog
            Treatment of obesity and related disorders
TARGET      LEPR (CD295) [HSA:3953] [KO:K05062]
  PATHWAY   hsa04060(3953)  Cytokine-cytokine receptor interaction
            hsa04080(3953)  Neuroactive ligand-receptor interaction
            hsa04920(3953)  Adipocytokine signaling pathway
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AA Amino acids and derivatives
                 A16AA07 Metreleptin
                  D05014  Metreleptin (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Gastrointestinal Agents
              Gastrointestinal Agents, Other
               Metreleptin
                D05014  Metreleptin (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               249  Miscellaneous
                2499  Others
                 D05014  Metreleptin (USAN/INN); Mettreleptin (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                LEPR (CD295)
                 D05014  Metreleptin (USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D05014
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D05014
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D05014
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D05014
DBLINKS     CAS: 186018-45-1
            PubChem: 47206741
///
